BACKGROUND: Data on temporal trends in outcomes, gender differences, and adherence to evidence-based therapy (EBT) of diabetic patients with ST-segment elevation myocardial infarction (STEMI) are sparse. METHODS: We performed a retrospective analysis of prospectively acquired data on 3565 diabetic (2412 males and 1153 females) STEMI patients enrolled in the Swiss AMIS Plus registry between 1997 and 2010 and compared in-hospital outcomes and adherence to EBT with the nondiabetic population (n=15,531). RESULTS: In-hospital mortality dramatically decreased in diabetic patients, from 19.9% in 1997 to 9.0% in 2010 (p trend<0.001) with an age-adjusted decrease of 6% per year of admission. Similar trends were observed for age-adjusted reinfarction (OR 0.86, p<0.001), cardiogenic shock (OR 0.88, p<0.001), as well as death, reinfarction, or stroke (OR 0.92, p<0.001). However, the mortality benefit over time was observed in diabetic males (p trend=0.006) but not females (p trend=0.082). In addition, mortality remained twice as high in diabetic patients compared with nondiabetic ones (12.1 vs. 6.1%, p<0.001) and diabetes was identified as independent predictor of mortality (OR 1.23, p=0.022). Within the diabetic cohort, females had higher mortality than males (16.1 vs. 10.2%, p<0.001) and female gender independently predicted in-hospital mortality (OR 1.45, p=0.015). Adherence to EBT significantly improved over time in diabetic patients (p trend<0.001) but remained inferior - especially in women - to the one of nondiabetic individuals. CONCLUSIONS: In-hospital mortality and morbidity of diabetic STEMI patients in Switzerland improved dramatically over time but, compared with nondiabetic counterparts, gaps in outcomes as well as EBT use persisted, especially in women.
BACKGROUND: Data on temporal trends in outcomes, gender differences, and adherence to evidence-based therapy (EBT) of diabeticpatients with ST-segment elevation myocardial infarction (STEMI) are sparse. METHODS: We performed a retrospective analysis of prospectively acquired data on 3565 diabetic (2412 males and 1153 females) STEMI patients enrolled in the Swiss AMIS Plus registry between 1997 and 2010 and compared in-hospital outcomes and adherence to EBT with the nondiabetic population (n=15,531). RESULTS: In-hospital mortality dramatically decreased in diabeticpatients, from 19.9% in 1997 to 9.0% in 2010 (p trend<0.001) with an age-adjusted decrease of 6% per year of admission. Similar trends were observed for age-adjusted reinfarction (OR 0.86, p<0.001), cardiogenic shock (OR 0.88, p<0.001), as well as death, reinfarction, or stroke (OR 0.92, p<0.001). However, the mortality benefit over time was observed in diabetic males (p trend=0.006) but not females (p trend=0.082). In addition, mortality remained twice as high in diabeticpatients compared with nondiabetic ones (12.1 vs. 6.1%, p<0.001) and diabetes was identified as independent predictor of mortality (OR 1.23, p=0.022). Within the diabetic cohort, females had higher mortality than males (16.1 vs. 10.2%, p<0.001) and female gender independently predicted in-hospital mortality (OR 1.45, p=0.015). Adherence to EBT significantly improved over time in diabeticpatients (p trend<0.001) but remained inferior - especially in women - to the one of nondiabetic individuals. CONCLUSIONS: In-hospital mortality and morbidity of diabetic STEMI patients in Switzerland improved dramatically over time but, compared with nondiabetic counterparts, gaps in outcomes as well as EBT use persisted, especially in women.
Authors: Gerard X Brogan; Eric D Peterson; Jyotsna Mulgund; Deepak L Bhatt; E Magnus Ohman; W Brian Gibler; Charles V Pollack; Michael E Farkouh; Matthew T Roe Journal: Diabetes Care Date: 2006-01 Impact factor: 19.112
Authors: Matthew T Roe; Lori S Parsons; Charles V Pollack; John G Canto; Hal V Barron; Nathan R Every; William J Rogers; Eric D Peterson Journal: Arch Intern Med Date: 2005-07-25
Authors: Deepak L Bhatt; Matthew T Roe; Eric D Peterson; Yun Li; Anita Y Chen; Robert A Harrington; Adam B Greenbaum; Peter B Berger; Christopher P Cannon; David J Cohen; C Michael Gibson; Jorge F Saucedo; Neal S Kleiman; Judith S Hochman; William E Boden; Ralph G Brindis; W Frank Peacock; Sidney C Smith; Charles V Pollack; W Brian Gibler; E Magnus Ohman Journal: JAMA Date: 2004-11-03 Impact factor: 56.272
Authors: Richard M Cubbon; Stephen B Wheatcroft; Peter J Grant; Christopher P Gale; Julian H Barth; Robert J Sapsford; Ramzi Ajjan; Mark T Kearney; Alistair S Hall Journal: Eur Heart J Date: 2007-02-08 Impact factor: 29.983
Authors: Sean M Donahoe; Garrick C Stewart; Carolyn H McCabe; Satishkumar Mohanavelu; Sabina A Murphy; Christopher P Cannon; Elliott M Antman Journal: JAMA Date: 2007-08-15 Impact factor: 56.272
Authors: Stephen D Wiviott; Eugene Braunwald; Dominick J Angiolillo; Simha Meisel; Anthony J Dalby; Freek W A Verheugt; Shaun G Goodman; Ramon Corbalan; Drew A Purdy; Sabina A Murphy; Carolyn H McCabe; Elliott M Antman Journal: Circulation Date: 2008-08-31 Impact factor: 29.690
Authors: Sumeet Subherwal; Richard G Bach; Anita Y Chen; Brian F Gage; Sunil V Rao; L Kristin Newby; Tracy Y Wang; W Brian Gibler; E Magnus Ohman; Matthew T Roe; Charles V Pollack; Eric D Peterson; Karen P Alexander Journal: Circulation Date: 2009-03-30 Impact factor: 29.690
Authors: Sarah Rosner Preis; Shih-Jen Hwang; Sean Coady; Michael J Pencina; Ralph B D'Agostino; Peter J Savage; Daniel Levy; Caroline S Fox Journal: Circulation Date: 2009-03-23 Impact factor: 29.690
Authors: Romana Herscovici; James Mirocha; Jed Salomon; Noel B Merz; Bojan Cercek; Michael Goldfarb Journal: Eur Heart J Acute Cardiovasc Care Date: 2019-08-27
Authors: Dragana Radovanovic; Burkhardt Seifert; Marco Roffi; Philip Urban; Hans Rickli; Giovanni Pedrazzini; Paul Erne Journal: Open Heart Date: 2017-11-14